EVERTEC, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EVERTEC, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $453.87M | Feb 26, 2019 |
| FY2018 | Dec 31, 2017 | $407.14M | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $389.51M | Feb 26, 2019 |
| FY2017 | Dec 31, 2015 | $373.53M | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $361.79M | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $358.40M | May 26, 2016 |
| FY2014 | Dec 31, 2012 | $342.49M | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $321.12M | Mar 17, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $931.82M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $845.49M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $694.71M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $618.41M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $589.80M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $510.59M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $487.37M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $453.87M | Mar 1, 2021 |
| FY2018 | Sep 30, 2018 | $453.87M | Feb 26, 2019 |
| FY2019 | Dec 31, 2017 | $407.14M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.59M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $112.62M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $79.72M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $239.01M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $161.13M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $104.44M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $103.47M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $86.27M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $55.05M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $75.04M | Feb 26, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $186.44M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $165.67M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $136.16M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $157.40M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $196.51M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $141.39M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $144.50M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $125.13M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $86.08M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $107.15M | Feb 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $154.16M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $145.56M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $128.17M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $89.77M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $68.05M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $70.81M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $61.41M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $68.72M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $56.16M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $46.99M | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $227.01M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $260.06M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $211.19M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $219.90M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $228.42M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $199.09M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $179.95M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $172.73M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $145.79M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $168.05M | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.34M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $25.38M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $21.43M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $27.07M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $25.10M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $17.08M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $23.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $13.93M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $11.29M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $18.45M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.24B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.86B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $2.06B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.13B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.14B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.07B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.01B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $927.29M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $902.79M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $885.66M | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.53B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.34B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.42B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $657.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $674.49M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $730.15M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $740.05M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $711.69M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $754.81M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $777.49M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $621.61M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $472.52M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $594.29M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $471.51M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $466.21M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $337.74M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $267.19M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $211.46M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $144.11M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $104.68M | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $891.99M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $726.90M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $791.70M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $423.39M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $393.32M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $397.67M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $399.49M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $394.64M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $398.58M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $370.99M | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $687.70M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $599.61M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $538.90M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $487.35M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $506.05M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $379.93M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $296.48M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $228.74M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $148.89M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $116.34M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $305.99M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $273.65M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $295.60M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $185.27M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $257.86M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $202.65M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $111.03M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $69.97M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $50.42M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $51.92M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $978.09M | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $410.25M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $465.29M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $496.73M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $527.60M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $538.61M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $616.74M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $650.76M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $662.70M | Feb 24, 2017 |
| FY2015 | Dec 31, 2014 | $693.91M | May 26, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 26, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 61.76M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 63.61M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 65.45M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 64.85M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 71.97M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 72.14M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 72.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 72.38M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 72.39M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | 72.64M | Feb 28, 2018 |